Hip Insertional Tendinopathy

Author(s):  
Giulio Ferrero ◽  
Emanuele Fabbro ◽  
Angelo Corazza
2006 ◽  
Vol 16 (4) ◽  
pp. 329-334 ◽  
Author(s):  
Nicola Maffulli ◽  
Jacqueline Reaper ◽  
Stanley WB. Ewen ◽  
Stuart W. Waterston ◽  
Victoria Barrass

2007 ◽  
Vol 41 (8) ◽  
pp. e11-e11 ◽  
Author(s):  
D. N Bhatia ◽  
J. F de Beer ◽  
K. S van Rooyen ◽  
F. Lam ◽  
D. F du Toit

2007 ◽  
Vol 12 (4) ◽  
pp. 597-615 ◽  
Author(s):  
Matthew Solan ◽  
Mark Davies

2019 ◽  
Vol 4 (4) ◽  
pp. 2473011419S0027
Author(s):  
Matt Levitsky ◽  
Justin Greisberg ◽  
J Turner Vosseller ◽  
Shirin Dey ◽  
Briana Hickey

Category: Sports Introduction/Purpose: Achilles tendinopathy is a common clinical entity encountered by orthopaedic surgeons, although the demographics of patients that suffer from this pathology are incompletely understood. It has been suggested that there may be differences in patients that get insertional (IAT) and noninsertional Achilles tendinopathy (NIAT), and our clinical experience has been that older, less active patients tend to get insertional tendinopathy. The goal of this study is to further investigate the features of patients in a single institution who presented with Achilles tendinopathy. Methods: We used ICD-9 and ICD-10 codes to find patients who presented with Achilles tendinopathy to two foot and ankle surgeons at one academic medical center from 2007-2018. We made note of patient characteristics such as age, gender, BMI, medical comorbidities, and level of activity. Physical examination, including the presence of a gastrocnemius equinus, was noted as well. Characteristics of insertional and non-insertional tendinopathy subgroups were compared using Student’s T-tests and chi- squared tests. Results: The characteristics of 948 consecutive patients were analyzed. The mean age was 55 years and 50.5% of the patients were male. Patients with IAT had significantly higher BMIs than did those with NIAT (30.5 compared to 28.0, p < .05). The mean age was 54.5 years in the IAT group compared to 55.8 years in the NIAT group (p>.05). Patients with NIAT self-identified as active a greater percentage of the time (63% vs 45%, p<0.5). 76% of the IAT group had a gastrocnemius equinus on physical examination, compared to 67% of the non-insertional group. Antecedent fluoroquinolone antibiotic use was only reported in 10% of patients, and all of these patients presented with NIAT. Conclusion: The age at which patients present with insertional and noninsertional Achilles tendinopathy is not significantly different, although patients with NIAT had a lower BMI and self-identified as active a greater percentage of the time. A gastrocnemius equinus was present in a high percentage of patients with both IAT and NIAT. Fluoroquinolone use was not involved in most cases, although, when it was, patients presented with NIAT.


Author(s):  
Nicola Maffulli ◽  
Amol Saxena ◽  
Emilio Wagner ◽  
Guglielmo Torre

Achilles tendon pathology is a most common musculoskeletal condition in active individuals and athletes. Almost 6% of the general population will suffer from such ailment in their lifetime. Insertional Achilles tendinopathy (IAT) differs in its physiopathology, clinical features and treatment from midportion tendinopathy. The literature has mainly focused on assessment, outcome evaluation and treatment of IAT, although differences in management according to different geographical regions have not been addressed. The principles of clinical evaluation and imaging assessment of IAT are well established, with a major role of clinical assessment and soft tissue imaging, including ultrasonography and MRI. Conservative management options include eccentric training, extracorporeal shockwave therapy and prolotherapy, or a combination of these modalities. Recently, regenerative medicine has been more widely used, with at times dubious results. Surgery is advocated where conservative treatment is not beneficial within 6 months. Surgery includes more or less extensive debridement of peritendinous bony and soft tissue structures. To improve our knowledge about IAT, more evidence should be provided concerning innovative treatments, especially considering growth factors injections and percutaneous surgery.


2013 ◽  
Vol 04 (06) ◽  
pp. 1-4
Author(s):  
Giovanni Carcuro ◽  
Leonardo Lagos ◽  
Hugo Henríquez ◽  
Natalio Cuchacovich ◽  
Manuel Pellegrini ◽  
...  

BMJ Open ◽  
2017 ◽  
Vol 7 (1) ◽  
pp. e013332 ◽  
Author(s):  
Nacime Salomão Barbachan Mansur ◽  
Flávio Faloppa ◽  
João Carlos Belloti ◽  
Sheila J McNeill Ingham ◽  
Fabio Teruo Matsunaga ◽  
...  

2016 ◽  
Vol 25 (6) ◽  
pp. 1839-1848 ◽  
Author(s):  
Qi Zhang ◽  
Yehua Cai ◽  
Yinghui Hua ◽  
Jun Shi ◽  
Yuanyuan Wang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document